| Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Cash collections from financial royalty assets | 2,122 | 2,316 | 2,507 | 3,201 | 2,983 |
|---|
| Cash collections from intangible royalty assets | 144 | 151 | 73 | 1 | 15 |
|---|
| Other royalty cash collections | 18 | 44 | 70 | 159 | 109 |
|---|
| Distributions from equity method investees | 42 | 34 | 39 | 19 | 13 |
|---|
| Interest received | 8 | 3 | 25 | 72 | 46 |
|---|
| Development-stage funding payments - ongoing | 20 | 7 | 2 | 2 | 2 |
|---|
| Development-stage funding payments - upfront and milestone | 6 | 193 | 175 | 50 | - |
|---|
| Payments for operating and professional costs | 180 | 185 | 223 | 243 | 236 |
|---|
| Interest paid | 103 | 130 | 170 | 169 | 160 |
|---|
| Net cash provided by operating activities | 2,035 | 2,018 | 2,144 | 2,988 | 2,769 |
|---|
| Distributions from equity method investees | 15 | 1 | - | 44 | 24 |
|---|
| Investments in equity method investees | 40 | 35 | 10 | 13 | 11 |
|---|
| Purchases of equity securities | 50 | 135 | 88 | - | 63 |
|---|
| Proceeds from equity securities | 385 | 116 | 211 | - | 99 |
|---|
| Purchases of available for sale debt securities | - | 70 | 480 | - | 150 |
|---|
| Proceeds from available for sale debt securities | 3 | 63 | 542 | 1 | 20 |
|---|
| Purchases of marketable securities | 1,705 | 1,197 | 235 | - | - |
|---|
| Proceeds from Sale and Maturity of Marketable Securities | 815 | 1,598 | 792 | 24 | - |
|---|
| Acquisitions of financial royalty assets | 2,182 | 2,192 | 1,742 | 2,116 | 2,506 |
|---|
| Acquisitions of other financial assets | - | - | 21 | - | 18 |
|---|
| Milestone payments | - | 19 | - | 12 | 75 |
|---|
| Other | - | - | - | 2 | -2 |
|---|
| Net cash used in investing activities | -2,759 | -1,870 | -1,029 | -2,073 | -2,678 |
|---|
| Distributions to legacy non-controlling interests - Portfolio Receipts | - | - | 442 | 377 | 362 |
|---|
| Distributions to legacy non-controlling interests - other | 181 | 154 | 31 | - | - |
|---|
| Distributions to continuing non-controlling interests | 544 | 480 | 144 | 120 | 125 |
|---|
| Dividends to shareholders | 112 | 285 | 333 | 358 | 376 |
|---|
| Repurchases of Class A ordinary shares | - | - | - | 305 | 230 |
|---|
| Contributions from legacy non-controlling interests - R&D | 8 | 7 | 1 | 1 | 1 |
|---|
| Proceeds From Noncontrolling Interests, Other | 59 | 37 | 6 | 7 | 4 |
|---|
| Cash acquired in connection with purchase of non-controlling interest | - | - | - | 5 | - |
|---|
| Proceeds from revolving credit facility | - | - | - | 350 | - |
|---|
| Repayment of revolving credit facility | - | - | - | 350 | - |
|---|
| Repayment of long-term debt | - | - | - | 1,000 | - |
|---|
| Proceeds from Issuance of Other Long-Term Debt | - | - | - | - | 1,471 |
|---|
| Debt issuance costs and other | 47 | 13 | 1 | 2 | 13 |
|---|
| Other | - | - | - | - | -9 |
|---|
| Net cash provided by/(used in) in financing activities | 1,487 | 385 | -945 | -2,149 | 361 |
|---|
| Net change in cash and cash equivalents | 762 | 532 | 170 | -1,234 | 452 |
|---|